| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 10308 | 2013 |
| A mammalian microRNA expression atlas based on small RNA library sequencing P Landgraf, M Rusu, R Sheridan, A Sewer, N Iovino, A Aravin, S Pfeffer, ... Cell 129 (7), 1401-1414, 2007 | 4532 | 2007 |
| Genomic aberrations and survival in chronic lymphocytic leukemia H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, ... New England Journal of Medicine 343 (26), 1910-1916, 2000 | 4406 | 2000 |
| Driver mutations in histone H3. 3 and chromatin remodelling genes in paediatric glioblastoma J Schwartzentruber, A Korshunov, XY Liu, DTW Jones, E Pfaff, K Jacob, ... Nature 482 (7384), 226-231, 2012 | 2736 | 2012 |
| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2482 | 2018 |
| Molecular subgroups of medulloblastoma: the current consensus MD Taylor, PA Northcott, A Korshunov, M Remke, YJ Cho, SC Clifford, ... Acta neuropathologica 123, 465-472, 2012 | 2136 | 2012 |
| Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 2011 | 2012 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1905* | 2020 |
| High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones P Lichter, CJC Tang, K Call, G Hermanson, GA Evans, D Housman, ... Science 247 (4938), 64-69, 1990 | 1699 | 1990 |
| Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries P Lichter, T Cremer, J Borden, L Manuelidis, DC Ward Human genetics 80, 224-234, 1988 | 1503 | 1988 |
| Matrix‐based comparative genomic hybridization: biochips to screen for genomic imbalances S Solinas‐Toldo, S Lampel, S Stilgenbauer, J Nickolenko, A Benner, ... Genes, chromosomes and cancer 20 (4), 399-407, 1997 | 1444 | 1997 |
| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1420 | 2018 |
| Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib JA Woyach, RR Furman, TM Liu, HG Ozer, M Zapatka, AS Ruppert, L Xue, ... New England Journal of Medicine 370 (24), 2286-2294, 2014 | 1405 | 2014 |
| A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling M Hummel, S Bentink, H Berger, W Klapper, S Wessendorf, TFE Barth, ... New England Journal of Medicine 354 (23), 2419-2430, 2006 | 1203 | 2006 |
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1165 | 2012 |
| Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ... Cancer cell 27 (5), 728-743, 2015 | 1151 | 2015 |
| V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia A Kröber, T Seiler, A Benner, L Bullinger, E Brückle, P Lichter, ... Blood, The Journal of the American Society of Hematology 100 (4), 1410-1416, 2002 | 1100 | 2002 |
| The whole-genome landscape of medulloblastoma subtypes PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ... Nature 547 (7663), 311-317, 2017 | 1030 | 2017 |
| K27M mutation in histone H3. 3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas DA Khuong-Quang, P Buczkowicz, P Rakopoulos, XY Liu, ... Acta neuropathologica 124, 439-447, 2012 | 1008 | 2012 |
| p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias H Dohner, K Fischer, M Bentz, K Hansen, A Benner, G Cabot, D Diehl, ... | 995 | 1995 |
